“Assessment of Efficacy and Safety of Tislelizumab for Esophageal Squamous Cell Carcinoma”, JMHRP, vol. 2, no. 2, pp. 1–9, Oct. 2025, doi: 10.70844/jmhrp.2025.2.2.43.